| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,965,000 | 3,075,000 | 3,303,000 | 3,354,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 2,965,000 | 3,075,000 | 3,303,000 | 3,354,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,807,000 | 1,757,000 | 2,204,000 | 1,944,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 728,000 | 787,000 | 781,000 | 781,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 430,000 | 531,000 | 318,000 | 629,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 430,000 | 531,000 | 318,000 | 629,000 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 430,000 | 531,000 | 318,000 | 629,000 | | Income Tax Expense | 89,000 | 124,000 | 54,000 | 160,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 341,000 | 407,000 | 264,000 | 469,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 341,000 | 407,000 | 264,000 | 469,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $341,000 | $407,000 | $264,000 | $469,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
